November 24, 2024 19:23 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Mahayuti routs MVA in Maharashtra, INDIA retains Jharkhand; Priyanka's triumphant poll debut | How can Mahayuti win over 200 seats? Sanjay Raut cries foul over Maharashtra mandate | 'Third World War has begun:' Ex-Ukraine military commander-in-chief Valery Zaluzhny | UK-India Free Trade Agreement negotiations to resume in early 2024 | UK can arrest Benjamin Netanyahu if he visits country based on ICC warrant | Centre to send over 10,000 additional soldiers to violence-hit Manipur amid fresh violence | Chhattisgarh: 10 Maoists killed during encounter with security forces in Sukma | Baba Siddique murder case: Arrested Akashdeep Gill used a labourer's hotspot to evade tracking, say police | Donald Trump picks 'smart and tough' Pam Bondi as new US Attorney General after Matt Gaetz withdraws | Canadian government denies media report that claims PM Modi knew of Khalistani leader Nijjar's killing
Sinopharm
Image Credit: wikipedia.org

China's Sinopharm Covid-19 vaccine gets WHO's nod for emergency use

| @indiablooms | Sep 19, 2024, at 01:37 am

Geneva/IBNS: The World Health Organisation (WHO) on Friday gave emergency use approval for a coronavirus vaccine made by China's state-owned drug manufacturer Sinopharm, said a Reuters report.

The vaccine is one of the two shots made by China and has been exported to several countries and given to millions of people in China, according to the report.

It is also the first vaccine made by a non-western country to get the UN health body's approval and also the first Chinese vaccine to get its nod for any infectious disease, the report said.

This draws significance as WHO's approval is a benchmark of safety and efficacy of a product for countries. It also means that the Chinese vaccine can now be included in COVAX, the programme to make available coronavirus vaccine to poor countries across the globe.

Johnson & Johnson, AsyraZeneca, Pfizer-BioNTech and Moderna have so far received approval for emergency use from WHO.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.